| 000 | 01412 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516155244.0 | ||
| 264 | 0 | _c20131211 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdt234 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldkorn, A | |
| 245 | 0 | 0 |
_aTherapeutic windows and opportunity cost cast upon prostate cancer's fatal shore. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJul 2013 |
||
| 300 |
_a1717-1720 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAndrostenes |
| 650 | 0 | 4 |
_aAndrostenols _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDocetaxel |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aPhenylthiohydantoin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aTaxoids _xpharmacology |
| 700 | 1 | _aAparicio, A M | |
| 700 | 1 | _aQuinn, D I | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 24 _gno. 7 _gp. 1717-1720 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdt234 _zAvailable from publisher's website |
| 999 |
_c22864547 _d22864547 |
||